ReviewDrug delivery and translational research2023
Nanomedicine in therapeutic warfront against estrogen receptor-positive breast cancer.
Mayur Aalhate et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this paperpooled itcites it